MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study.
John S Kim1,2, Ani W Manichaikul3,4, Eric A Hoffman5
1Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA jk6jb@virginia.edu.
Thorax
|January 23, 2023
Summary
The MUC5B risk allele is linked to worsening lung interstitial abnormalities over time. This progression increases the risk of death and interstitial lung disease (ILD).
Area of Science:
- Pulmonary Medicine
- Genetics
- Radiology
Background:
- The MUC5B promoter variant and telomere length are known risk factors for pulmonary fibrosis.
- Their association with longitudinal quantitative changes in the lung interstitium is not well understood.
Purpose of the Study:
- To investigate the association of the MUC5B risk allele and telomere length with longitudinal changes in lung interstitial abnormalities.
- To examine the impact of these changes on mortality and interstitial lung disease (ILD) risk.
Main Methods:
- Utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA) including high-attenuation areas (HAAs) from CT scans (n=4552).
- Employed linear mixed-effects models to assess the relationship between MUC5B genotype, telomere length, and HAAs over time (Examinations 1-6).
- Used joint models to link longitudinal HAA changes with mortality and ILD outcomes.
Main Results:
- The MUC5B risk allele (T) was associated with a 2.60% increase in HAAs per decade.
- This association was more pronounced in individuals with shorter telomere lengths (interaction p=0.008).
- Each 1% annual increase in HAAs correlated with a 7% higher mortality risk and a 34% higher ILD risk.
Conclusions:
- Longitudinal increases in lung interstitial abnormalities, indicated by HAAs, are associated with the MUC5B risk allele.
- Progressive interstitial changes independently predict increased risk of death and interstitial lung disease (ILD).


